Summary. Fibrocalculous pancreatic diabetes (previously known as tropical pancreatic diabetes) is a rare cause of diabetes confined to countries within the tropical belt. The aetiology of fibrocalculous pancreatic diabetes is thought to be environmental although the agent(s) is unknown. We have investigated a possible genetic basis of this disease by looking for restriction fragment length polymorphisms of genes implicated in the aetiology of diabetes rnellitus. Seventy-six Dravidian patients with fibrocalculous pancreatic diabetes were studied, and the restriction fragment length polymorphisms obtained compared to racially matched control subjects (n=94), patients with Type2 (non-insulin-dependent) diabetes (n=87) and Type 1 (insulin-dependent) diabetes (n = 58). No association of fibrocalculous pancreatic diabetes was found with restriction fragment length polymorphisms of the insulin receptor gene. Although no association of fibrocalculous pancreatic diabetes was found with polymorphism of the HLA DRc~/DQc~/DXct genes, an association was found with the Taq 1 restriction fragment length polymorphisms of the DQ[~ gene (DQ[~ T2/T6 present in 39% of patients with fibrocalculous pancreatic diabetes compared to 19% in control subjects; p = 0.01 ; corrected p value = 0.04) which is similar to that found in Type 1 but not Type 2 diabetes. An association of fibrocalculous pancreatic diabetes was also found with the hypervariable region in the 5-prime flanking region of the insulin gene; 40% of patients possessed the class 3 allele compared to 9.5% of control subjects p = 0.0001 ; corrected p value = 0.0008). In Type 2 diabetes, similar results were obtained with 33% subjects possessing the class 3 allele (t7 value compared to control subjects = 0.0005; corrected p value = 0.004). This study suggests that fibrocalculous pancreatic diabetes has a genetic component in its aetiology. Furthermore, its origin might be related to an individual with part of the genetic predisposition to diabetes (Type 1 or Type 2) who additionally has evidence of chronic calcific pancreatitis.
Malnutrition related diabetes mellitus (MRDM) is a rare cause of diabetes confined to countries in the tropical belt [1] . The World Health Organisation study group on diabetes has recommended its classification into two sub-types, namely protein deficient pancreatic diabetes (PDPD) and fibrocalculous pancreatic diabetes (FCPD) [2] .
PDPD was first described by Hugh-Jones in Jamaica (previously known as J-type diabetes) and is characterised by resistance to ketosis on withdrawal of insulin, young age of onset and extreme leanness [3] . However, all these features can easily be confused with the more common forms of diabetes seen in South India [4] . In contrast, FCPD (previously known as tropical pancreatic diabetes) can be well defined, e.g. diabetes associated with chronic pancreatitis not due to a known cause of pancreatitis (for instance, alcoholism, gall stones, etc); the patient usually requires insulin for control of hyperglycaemia and is still ketosis resistant, frequently has a low body mass index (less than 18), evidence of pancreatic calculi on plain abdominal x-ray and often a past history of recurrent abdominal pain in childhood [4] [5] [6] [7] .
The aetiology of FCPD is not clear and is thought principally to involve environmental rather than genetic causes. The environmental agents proposed include cassava ingestion, malnutrition, and chronic viral infections; however, these factors remain controversial [8] [9] [10] . ,Am alternative hypothesis is that chronic pancreatitis seen in the tropics produces limited B-cell destruction in an individual with a genetic predisposition to diabetes mellitus. A genetic aetiology to this disease has been suggested by Pitchumoni who observed an increased clustering of FCPD within families; however, this could equally be due to environmental factors [11] .
We have investigated a possible genetic basis of FCPD by searching for restriction fragment length polymorphisms of genes previously studied in diabetes mellitus which might associate with FCPD. Results in FCPD were compared with those found in South Indian subjects who either had Type 1 (insulin-dependent) or Type 2 (non-insulin-dependent) diabetes to investigate a possible genetic link between these diseases and FCPD. The Type 2 diabetic population in South India provided new data in its own right, since genetic polymorphisms linked to this disease has not previously been sought in this ethnic group in which there is a high familial occurrence of diabetes [12] .
Subjects and methods

Diabetic patients
All patient groups were unrelated Dravidian subjects consisting of 76 patients with FCPD, 87 with Type 2 diabetes and 58 with Type 1 diabetes. For technical reasons, not all patients were studied with all gene probes. Clinical characteristics of the patient groups are presented in Table 1 .
Type 2 diabeteswas defined by an insidious onset of disease, and, if on insulin, this treatment had not been initiated within five years of the diagnosis; in no subject had significant ketosis been observed.
Type 1 diabetes was defined by an acute onset of symptoms, onset of disease before the age of 35 years, proneness to ketosis and an absolute dependence on exogenously administered insulin from the time of diagnosis. In all patients with Type i diabetes, abdominal x-ray and ultrasound of the pancreas were normal.
FCPD was defined by the following criteria:
1. Diabetes mellitus as defined by the WHO Study Group.E 2. History of abdominal pain from childhood. 3. Radiological evidence of pancreatic calculi. 4. Confirmation of presence of calculi and/or pancreatic fibrosis and ductal dilation on ultrasonography. 5. The absence of known causes of chronic pancreatitis, e.g. alcoholism, gall stones, etc.
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Assessment of diabetic complications
Atherosclerosis. Atherosclerosis was defined if there was evidence of ischaemic heart disease and/or peripheral vascular disease. All patients had a resting ECG taken. Ischaemic heart disease was considered to be present if there was a clear history of angina pectoris or myocardial infarction and/or the ECG demonstrated evidence of myocardial infarction or left bundle branch block. Peripheral vascular dise, ase was deemed to be present if there was a history of intermittent claudication or if one or more peripheral pulse (dorsalis pedis or posterior tibial) was absent.
Microangiopathy. Microangiopathy was defined if there was evidence of neuropathy and/or retinopathy and/or nephropathy. Neuropathy was defined as the absence of ankle jerks bilaterally and/or a glove and stocking neuropathy. The fundi were examined by an ophthalmologist both by direct and indirect ophthalmoscopy. Diabetic retinopathy was deemed present if there was either background or proliferative retinopathy as defined by Kohner et al. [13] . Nephropathy was defined by 1) estimating the 24 h urinary protein excretion by the sulphosalicylic acid method [14] -those with values greater than 500 mg, in tl~e absence of urinary tract infection or severe hypertension, were considered to have nephropathy or 2) a serum creatinine of greater than 133 ~mol/1.
Control subjects
Ninety-four unrelated Dravidian control subjects without a first degree family history of diabetes were recruited either from blood donors (control group 1 ; n = 45) or from staff and spouses of patients at the MV Hospital for diabetes (control group 2; n = 49). Detailed clinical data is presented in Table 1 for control group 2; in all subjects, random blood glucose values were below 6.7 mmol/1. In five individuals, there was a second degree family history of Type 2 diabetes, and in the rest, there was no family history of diabetes mellitus.
MeNo~
DNA was extracted from 10 ml of blood (transported to the UK at -20~ and digested with restriction endonucleases (Boehringer Mannheim, Cambridge, UK). The resulting DNA fragments were separated according to size by agarose gel electrophoresis and transferred to a nylon membrane (Gene Screen Plus, New England Nuclear, Boston, Mass, USA) by Southern blotting as previously a Body mass index and lipid values were taken at first presentation of diabetes; b Control group 2: Random blood sugar 5.9 +-0.7 mmol/1; HbA1 7.4 +_ 0.2 (normal range = 5-8%). In control group 1 (n = 45) no clinical details are available apart from that all had no personal or family history of diabetes; c Age at inclusion of study Key: FH = first degree family history of Type 2 diabetes; Chol = cholesterol; Trig= triglyceride ; n = number; BMI =body mass index; Athero=atherosclerosis (ischaemic heart disease/peripheral vascular disease); micro=microvascular disease (retinopathy/neuropathy/nephropathy); OHA = oral hypoglycaemic agents; INS = insulin described [15] . The appropriate probe was labelled with 32p labelled cytosine triphosphate and hybridised to the filter according to the manufacturer's protocol (New England Research Products, Boston, Mass, USA). Autoradiography was carried out at -70 ~ on Kodak XAR5 film. Gene related sequences were sized by comparison with Hind III digested )~ phage DNA and internal standards.
The following probes and enzymes were used:
Insulin receptor. This is located on chromosome 17, and is a 4.1 kb cDNA fragment containing the coding region of the c~ and ~ chain of the insulin receptor [16] . The probe was excised from the plasmid vector using Eco RI restriction endonuclease. Patient DNA was digested with restriction enzyme Rsa I.
Insulin gene (pHins 310
). This is located on chromosome 11 and encodes the hypervariable region flanking the insulin gene [17] . The 0.87 kb fragment was excised from the plasmid vector using Barn HI restriction endonuclease. Patient DNA was digested with the restriction enzyme Pvu II.
HLA-D region probes: DReq DQa and DQ3. All are located on the short arm of chromosome6. DRa is a Pst I cDNA fragment, 0.3-0.5 kb in length [18] . DQc~ is a Pst 1 2.0 kb genomic fragment and also identifies with the DXc~ gene [19] . DQ[~ is a Ava I cDNA fragment of pDR[31, 0.6 kb in length [20] . Patient DNA was digested with Bgl II (DRc 0 and Taq 1 (DQa/DQ[3). 
Statistical analysis
Results were analysed by Chi square using a Yates correction for small numbers when appropriate [21] . Where significant associations were found the p values were multiplied by the number of comparisons (pc) made within each individual experiment, (e.g. subject group -in all cases 4 -multiplied by the number of independent markers within each experiment), and relative risk and 95% confidence limits were calculated by the method of Woolf [22] . Analysis of variance was used for comparison of mean values between study groups [23] .
Results
Insulin receptor restriction fragment length polymorphisms
The Rsa I polymorphism was characterised by the presence of 7.4 and 6.3 kb bands. No differences were found between control subjects and patients with either FCPD or Type 2 diabetes (Table 2) .
Insulin gene RFLPs
Using Pvu II restriction endonuclease, and the hypervariable region probe, two alleles of the 5' flanking region designated Class 1 and Class 3 were detected [17] . ciated with higher levels of lipids compared to those subjects homozygous for the Class I allele (Table 3 b) . Those Type 2 diabetic subjects who had a first degree family history of diabetes were more likely to also possess the Class 3 allele (73% compared to 45% in those with a family history of Type 2 diabetes who were homozygous for the Class I allele; p = 0.04, pc= NS). This was not the case in FCPD or Type i diabetes.
DQa/ DXoc RFLPs
Using Taq I enzyme, five DQoc gene fragments were identified. These were sized 6.8, 6.2, 5.5, 4.6 and 2.6 kb [15] . The DXoc fragments sized 2.1 and 1.9 kb were also detected using the same probe [15] . Allelic frequencies for the DQa polymorphism (Table 4) shows no association with either FCPD or Type 2 diabetic subjects. The DQa 4.6kb fragment showed an association with Type 1 diabetes (32% vs 11% in control subjects) as previously documented [24] . No difference was found in allelic frequency of 2.1 and 1.9 kb DXa alleles (Table 5) . Only 41 Type 2 diabetic subjects were studied for DQrz/DXa RFLPs, as there were clearly no differences in distribution of alleles in Type 2 diabetic subjects compared to control subjects. (2) (subjects 4 and DQ[3T2/T6); correction factor 4) g Includes some subjects previously published [24] (95%: 1,1) and control group 2 (88%: 1,1); therefore, results were pooled for further analysis. Detailed results are shown in Table 3 
D~;~ RFLPs
Using Taq 1, we had previously identified two non-allelic fragments sized 2 kb (T2) and 6 kb (T6) which, when co-inherited in British Caucasoid subjects, closely associate with HLA DR4 [25, 26] . DQ[3 T2 was increased in FCPD and Type 1 diabetes compared to control subjects (Table 6 : control subjects 31% compared to FCPD 58%; pc=0.01 and Type I diabetes 60%; pc= 0.008). Although DQ[~ T2 was increased in Type 2 diabetes (49%; p= 0.03), this was not significantly different from control subjects when corrected for the number of comparisons made. DQ[3 T6 was found in 39~ of patients with FCPD compared to 46% of Type 1 diabetic subjects, 29.5% of Type 2 diabetic subjects and 19% of control subjects (FCPD compared to control subjects pc = 0.04).
D Re~ RFLPs
Using Bgl II, three allelic fragments were identified sized 4.5, 4.2 and 3.8 kb [15] . No association of these alleles were seen with FCPD and Type 2 diabetes. Only 45 subjects with Type 2 diabetes were studied as there was clearly no difference in DR(z alleles between patients and control subjects. The decreased prevalence of the 3.8 kb allele in Type 1 diabetes was as previously noted [24] (Table 7) .
Discussion
This study suggests that FCPD may result from a genetic predisposition to diabetes in patients who have evidence of chronic pancreatitis. The comparison of clinical data between FCPD, Type 1 and Type 2 diabetes highlights different clinical aspects of these three diseases (Table 1) . Body mass index (kg/m 2) in FCPD (19.2 + 2.7) was very similar to that in Type 1 diabetes (17.8 + 3.5); whereas, it was different to that in Type 2 diabetes (25.1 + 3.7). Mean age of onset in subjects with FCPD (27 + 8 years) was between the age of onset in subjects with Type1 (16+9 years) and Type 2 (45 +9 years) diabetes. Patients with FCPD and Type 1 diabetes had lower cholesterol and triglyceride values compared to subjects with Type 2 diabetes. Lastly, the majority of patients with FCPD required insulin for control of diabetes; although it is interesting to note that they required on average less units per kilogram than subjects with Type 1 diabetes and therefore, were not insulin resistant as is sometimes described.
Several loci have been postulated to be involved in the pathogenesis of Type 2 diabetes, in particular, the insulin receptor and insulin gene. The present insulin receptor data supports findings in other racial populations that there is no association of this locus with Type 2 diabetes [27-291. The finding of the Class 3 allele of the insulin gene associating with Type 2 diabetes (relative risk= 4.7; 95% confidence limits of 2.0-11.2) supports similar studies in European Caucasoids [30, 31] (UK and Denmark), Japanese subjects [32, 33] and American Caucasoids in San Francisco [34] . However, other population studies of American Caucasoids in Los Angeles [171, Pima Indians [35] , Punjabi Sikhs [27] and Naurian Indians [36] failed to find the same associations; indeed in one a Class 1 allele association was noted [17] . One explanation is that the primary association is not with Type 2 diabetes but with an associated disorder, e.g. hypertriglyceridaemia [37] or atherosclerosis [38] . However, data for this has also proved controversial [39] . In this study, no association was seen of atherosderosis (ischaemic heart disease and/or peripheral vascular disease) or hyperlipidaemia with the Class 3 allele in all disease groups (Table 3 B ). In one Japanese study, those Type 2 diabetic subjects with a family history of diabetes had an increased frequency of the Class 3 allele [321; although a trend was observed in this study 73% versus 45% of Type 2 diabetic subjects who were homozygous class 1, it was not statistically significant when corrected for the number of comparisons made, and the same association was not seen in FCPD or Type 1 diabetes. An alternative hypothesis is genetic heterogeneity, e.g. linkage in some racial groups between the Class 3 allele and Type 2 diabetes which is not present in other groups. This may be analogous to the association of a Hpa I RFLP of the [} globin gene in sickle cell anaemia which is found in West but not East 49 [24] Africans [40] . Family studies have failed to prove linkage of a subtype of Type 2 diabetes, maturity onset diabetesin the young, (MODY) with the insulin gene [41] [42] [43] . However, these families do not represent the common form of disease analysed in most population studies. One study has suggested linkage of hyperproinsulinaemia with the insulin gene haplotypes [44] . Finally it is likely that heterogeneity within Type 2 diabetes exists, further complicating the picture. Genes within the human MHC are not thought to be involved in the aetiology of Type 2 diabetes. However, in a previous study of Dravidian subjects [45] although no association of Type 2 diabetes was found with HLA-A, HLA-B, properdin factor B, second component of complement nor glyoxylase, an association was seen of the fourth component of complement (in particular, a decrease of C4B1 and an increase in C4B2). Furthermore, a weak association of HLA-Bw61 with South African Indians has recently been noted [46] . In our study, although there was an increase of DQ [3 T2 in Type 2 diabetic subjects (49%) compared to control subjects (31%; p=0.03), this was not statistically significant when corrected for the number of comparisons made in this experiment.
A consistent finding in both American and European Caucasoid subjects has been an association of the Class 1 allele of the insulin gene and Type 1 diabetes; the meaning of this association is unclear [17, 47] . This association is not seen in this study or Japanese or American black subjects with Type I diabetes [32, 33, 48] . These observations, therefore, rule out a direct relationship of the hypervariable region of the insulin gene in the predisposition to Type 1 diabetes but are compatible with a gene predisposing to Type 1 diabetes which is linked in some ethnic groups with the hypervariable region.
In our previous study of Type 1 diabetic Dravidian subjects, associations of diesease were noted with DQot 4.6 and DQ[~ T2 and DQ[~ T2/T6 [24] . No association of FCPD is seen with DQct 4.6 (Table 4) in contrast to the associations with DQ[} polymorphism (Table 6 ). This DQ[3 association might therefore indicate a common genetic predisposition to both FCPD and Type1 diabetes in Dravidian subjects. It is interesting to specu-late that because there is no DQc~ or DR0c association seen in FCPD in contrast to Type 1 diabetes (Tables 4  and 7 ) this might account for part of the phenotypic difference between the two diseases.
Particularly interesting was that 40% of patients with FCPD compared to 9.5% of control subjects possessed the Class 3 allele of the insulin gene locus (relative risk 6.2; 95% confidence limits 2.6-14.7). Thus, in Dravidian subjects the Class 3 allele of the insulin gene associates with FCPD and Type 2 diabetes. This indicates the possibility of Type 2 diabetes sharing a genetic factor with FCPD. Alternatively, the association of the Class 3 allele with FCPD might represent the high background population prevalence of Type 2 diabetes amongst South Indians [49] . Some overlap of FCPD patients was seen who had both the Class 3 allele and DQ[3 T2 (13/64; 20%) compared to 1/80 (1%) of the control subjects (~2=12.6; p=0.0004). 72.5% of FCPD patients had either or both the insulin and HLA DQ[3 markers compared to 39% of control subjects (Z 2 = 14.2; p= 0.0002).
In conclusion, this study suggests that fibrocalculous pancreatic diabetes arises in an individual who has part of the prexisting genetic susceptibility to either Type 1 or Type 2 diabetes and evidence of chronic pancreatitis. No conclusion can be reached as to the origin of the pancreatitis which might involve either or both genetic and environmental factors. Family studies are now in progress to ascertain whether segregation of the insulin gene and HLA markers can be found in pedigrees with a member who has FCPD.
